The House today passed legislation that would suspend through 2022 tariffs on certain infant formula base powders used to make infant formula in the United States. Congress in July passed legislation (H.R.8351) suspending tariffs on imported infant formula through 2022. The Food and Drug Administration has allowed formula imports to help address a U.S. formula shortage, but tariffs have increased the retail cost of these products. The Department of Health and Human Services offers a webpage  to help health care providers and families locate formula.
 

Related News Articles

Headline
AHA today urged Congress to take certain steps to strengthen the behavioral health workforce, reduce regulatory burdens for psychiatric facilities, and revise…
Headline
In a letter yesterday, AHA and other national organizations urged congressional leaders to prevent the Statutory Pay-As-You-Go Act of 2010 sequester from…
Headline
The Workgroup for Electronic Data Interchange advisory group yesterday urged Health and Human Services Secretary Xavier Becerra to work closely with standards…
Perspective
After Election Day, lawmakers will return to Washington to consider many important issues, including funding the government, the annual must-pass defense bill…
Headline
At an AHA virtual policy briefing today for congressional staff, hospital and health system leaders urged Congress to prioritize actions to address the…
Headline
As Congress begins to focus on its year-end agenda, AHA today urged lawmakers to prioritize certain actions to help hospitals and health systems address rising…